Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Protocol
  • Published:

Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood

Subjects

Abstract

The enzyme-linked immunospot (ELISPOT) assay was originally developed to enumerate antigen-specific antibody-secreting cells (ASCs), and has subsequently been adapted for various applications, including the detection cytokine-secreting cells. Owing to its exceptionally high sensitivity, the ELISPOT has proven to be especially useful for detecting discrete populations of active cells (e.g., antigen-specific cells). Because of its versatility, the ELISPOT assay is used for a wide range of applications, including clonal analyses of immune responses after vaccination or after immunotherapy. Here we describe standard protocols for the detection of human ASCs specific to virtually any vaccine antigen after enrichment of circulating plasmablasts. In addition, a protocol is described for the measurement of mucosal ASC responses after prior immunomagnetic enrichment of mucosally derived blood lymphocytes. The protocols described allow rapid (6–8 h) detection of specific ASCs in small (1–2 ml) samples of blood and can be performed in resource-poor settings.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Comparative kinetics of serological and blood ASC responses after immunization.
Figure 2: Schematic diagram of one-step and two-step ASC ELISPOT.
Figure 3: Influence of antigen coating concentration and blocking.
Figure 4: Comparison of Ficoll gradient and whole-blood lysis techniques for the detection of vaccine-specific IgG- and IgA-ASCs.
Figure 5: Detection of magnetically enriched blood ASCs.
Figure 6: Example of ELISPOT plate layout.
Figure 7: Anticipated results of the ELISPOT assay.

Similar content being viewed by others

References

  1. Plotkin, S. Vaccines: correlates of vaccine-induced immunity. Clin. Infect. Dis. 47, 401–409 (2008).

    Article  Google Scholar 

  2. Quiding, M. et al. Intestinal immune responses in humans. Oral cholera vaccination induces strong intestinal antibody responses and interferon-gamma production and evokes local immunological memory. J. Clin. Invest. 88, 143–148 (1991).

    Article  CAS  Google Scholar 

  3. Kozlowski, P.A., Cu-Uvin, S., Neutra, M.R. & Flanigan, T.P. Comparison of the oral, rectal, and vaginal immunization routes for induction of antibodies in rectal and genital tract secretions of women. Infect. Immun. 65, 1387–1394 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  4. Stevens, R.H., Macy, E., Morrow, C. & Saxon, A. Characterization of a circulating subpopulation of spontaneous antitetanus toxoid antibody producing B cells following in vivo booster immunization. J. Immunol. 122, 2498–2504 (1979).

    CAS  PubMed  Google Scholar 

  5. Yarchoan, R., Murphy, B.R., Strober, W., Clements, M.L. & Nelson, D.L. In vitro production of anti-influenza virus antibody after intranasal inoculation with cold-adapted influenza virus. J. Immunol. 127, 1958–1963 (1981).

    CAS  PubMed  Google Scholar 

  6. Kutteh, W.H., Koopman, W.J., Conley, M.E., Egan, M.L. & Mestecky, J. Production of predominantly polymeric IgA by human peripheral blood lymphocytes stimulated in vitro with mitogens. J. Exp. Med. 152, 1424–1429 (1980).

    Article  CAS  Google Scholar 

  7. Tarkowski, A. et al. Cellular origins of human polymeric and monomeric IgA: enumeration of single cells secreting polymeric IgA1 and IgA2 in peripheral blood, bone marrow, spleen, gingiva and synovial tissue. Clin. Exp. Immunol. 85, 341–348 (1991).

    Article  CAS  Google Scholar 

  8. Kutteh, W.H., Prince, S.J. & Mestecky, J. Tissue origins of human polymeric and monomeric IgA. J. Immunol. 128, 990–995 (1982).

    CAS  PubMed  Google Scholar 

  9. Friman, V. et al. Intestinal and circulating antibody-forming cells in IgA-deficient individuals after oral cholera vaccination. Clin. Exp. Immunol. 95, 222–226 (1994).

    Article  CAS  Google Scholar 

  10. Quiding, M. et al. Induction of specific antibody responses in the human nasopharyngeal mucosa. Adv. Exp. Med. Biol. 371B, 1445–1450 (1995).

    CAS  PubMed  Google Scholar 

  11. Quiding-Jarbrink, M. et al. Differential expression of tissue-specific adhesion molecules on human circulating antibody-forming cells after systemic, enteric, and nasal immunizations. A molecular basis for the compartmentalization of effector B cell responses. J. Clin. Invest. 99, 1281–1286 (1997).

    Article  CAS  Google Scholar 

  12. Kantele, A. Peripheral blood antibody-secreting cells in the evaluation of the immune response to an oral vaccine. J. Biotechnol. 26, 217–224 (1996).

    Article  Google Scholar 

  13. Kunkel, E. & Butcher, E. Plasma-cell homing. Nat. Rev. Immunol. 3, 822–829 (2003).

    Article  CAS  Google Scholar 

  14. Kunkel, E.J. et al. Lymphocyte CC chemokine receptor 9 and epithelial thymus-expressed chemokine (TECK) expression distinguish the small intestinal immune compartment: epithelial expression of tissue-specific chemokines as an organizing principle in regional immunity. J. Exp. Med. 192, 761–768 (2000).

    Article  CAS  Google Scholar 

  15. Bowman, E.P. et al. The intestinal chemokine thymus-expressed chemokine (CCL25) attracts IgA antibody-secreting cells. J. Exp. Med. 195, 269–275 (2002).

    Article  CAS  Google Scholar 

  16. Kunkel, E.J. et al. CCR10 expression is a common feature of circulating and mucosal epithelial tissue IgA Ab-secreting cells. J. Clin. Invest. 111, 1001–1010 (2003).

    Article  CAS  Google Scholar 

  17. Sundstrom, P., Lundin, S.B., Nilsson, L.A. & Quiding-Jarbrink, M. Human IgA-secreting cells induced by intestinal, but not systemic, immunization respond to CCL25 (TECK) and CCL28 (MEC). Eur. J. Immunol. 38, 3327–3338 (2008).

    Article  Google Scholar 

  18. Brandtzaeg, P. & Pabst, R. Let's go mucosal: communication on slippery ground. Trends Immunol. 25, 570–577 (2004).

    Article  CAS  Google Scholar 

  19. Sedgwick, J.D. & Holt, P.G. A solid-phase immunoenzymatic technique for the enumeration of specific antibody-secreting cells. J. Immunol. Methods 57, 301–309 (1983).

    Article  CAS  Google Scholar 

  20. Czerkinsky, C.C., Nilsson, L.A., Nygren, H., Ouchterlony, O. & Tarkowski, A. A solid-phase enzyme-linked immunospot (ELISPOT) assay for enumeration of specific antibody-secreting cells. J. Immunol. Methods 65, 109–121 (1983).

    Article  CAS  Google Scholar 

  21. Jerne, N.K. & Nordin, A.A. Plaque formation in agar by single antibody-producing cells. Science 140, 405 (1963).

    Article  Google Scholar 

  22. Engvall, E. & Perlmann, P. Enzyme-linked immunosorbent assay (ELISA). Quantitative assay of immunoglobulin G. Immunochemistry 8, 871–874 (1971).

    Article  CAS  Google Scholar 

  23. Towbin, H., Staehelin, T. & Gordon, J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc. Natl. Acad. Sci. USA 76, 4350–4354 (1979).

    Article  CAS  Google Scholar 

  24. Moller, S.A. & Borrebaeck, C.A. A filter immuno-plaque assay for the detection of antibody-secreting cells in vitro. J. Immunol. Methods 79, 195–204 (1985).

    Article  CAS  Google Scholar 

  25. Franci, C., Ingles, J., Castro, R. & Vidal, J. Further studies on the ELISA-spot technique. Its application to particulate antigens and a potential improvement in sensitivity. J. Immunol. Methods 88, 225–232 (1986).

    Article  CAS  Google Scholar 

  26. Czerkinsky, C., Moldoveanu, Z., Mestecky, J., Nilsson, L.A. & Ouchterlony, O. A novel two colour ELISPOT assay. I. Simultaneous detection of distinct types of antibody-secreting cells. J. Immunol. Methods 115, 31–37 (1988).

    Article  CAS  Google Scholar 

  27. Barington, T., Sparholt, S., Juul, L. & Heilmann, C. A simplification of the enzyme-linked immunospot technique. Increased sensitivity for cells secreting IgG antibodies to Haemophilus influenzae type B capsular polysaccharide. J. Immunol. Methods 156, 191–198 (1992).

    Article  CAS  Google Scholar 

  28. Lakew, M., Nordstrom, I., Czerkinsky, C. & Quiding-Jarbrink, M. Combined immunomagnetic cell sorting and ELISPOT assay for the phenotypic characterization of specific antibody-forming cells. J. Immunol. Methods 203, 193–198 (1997).

    Article  CAS  Google Scholar 

  29. Amano, M., Martin, J., McGhee, J., McCutcheon, M. & Kiyono, H. Immunofluorescence-digital image processing system for the quantitation of secreted immunoglobulin by single cells. J. Immunol. Methods 144, 127–140 (1991).

    Article  CAS  Google Scholar 

  30. Bromage, E., Stephens, R. & Hassoun, L. The third dimension of ELISPOTs: quantifying antibody secretion from individual plasma cells. J. Immunol. Methods 346, 75–79 (2009).

    Article  CAS  Google Scholar 

  31. Gazagne, A. et al. A Fluorospot assay to detect single T lymphocytes simultaneously producing multiple cytokines. J. Immunol. Methods 283, 91–98 (2003).

    Article  CAS  Google Scholar 

  32. Dosenovic, P. et al. Selective expansion of HIV-1 envelope glycoprotein-specific B cell subsets recognizing distinct structural elements following immunization. J. Immunol. 183, 3373–3382 (2009).

    Article  CAS  Google Scholar 

  33. Tarkowski, A., Czerkinsky, C. & Nilsson, L.A. Simultaneous induction of rheumatoid factor- and antigen-specific antibody-secreting cells during the secondary immune response in man. Clin. Exp. Immunol. 61, 379–387 (1985).

    CAS  PubMed  PubMed Central  Google Scholar 

  34. Carpenter, C.M. et al. Comparison of the antibody in lymphocyte supernatant (ALS) and ELISPOT assays for detection of mucosal immune responses to antigens of enterotoxigenic Escherichia coli in challenged and vaccinated volunteers. Vaccine 24, 3709–3718 (2006).

    Article  CAS  Google Scholar 

  35. Chang, H.S. & Sack, D.A. Development of a novel in vitro assay (ALS assay) for evaluation of vaccine-induced antibody secretion from circulating mucosal lymphocytes. Clin. Diagn. Lab. Immunol. 8, 482–488 (2001).

    CAS  PubMed  PubMed Central  Google Scholar 

  36. Qadri, F. et al. Antigen-specific immunoglobulin A antibodies secreted from circulating B cells are an effective marker for recent local immune responses in patients with cholera: comparison to antibody-secreting cell responses and other immunological markers. Infect. Immun. 71, 4808–4814 (2003).

    Article  CAS  Google Scholar 

  37. Baqar, S. et al. Standardization of measurement of immunoglobulin-secreting cells in human peripheral circulation. Clin. Diagn. Lab. Immunol. 4, 375–379 (1997).

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Kyu, S. et al. Frequencies of human influenza-specific antibody secreting cells or plasmablasts post vaccination from fresh and frozen peripheral blood mononuclear cells. J. Immunol. Methods 340, 42–47 (2009).

    Article  CAS  Google Scholar 

  39. Rott, L.S., Briskin, M.J. & Butcher, E.C. Expression of α4β7 and E-selectin ligand by circulating memory B cells: implications for targeted trafficking to mucosal and systemic sites. J. Leukoc. Biol. 68, 807–814 (2000).

    CAS  PubMed  Google Scholar 

  40. Mei, H. et al. Blood-borne human plasma cells in steady state are derived from mucosal immune responses. Blood 113, 2461–2469 (2009).

    Article  CAS  Google Scholar 

  41. Nygren, H., Czerkinsky, C. & Stenberg, M. Dissociation of antibodies bound to surface-immobilized antigen. J. Immunol. Methods 85, 87–95 (1985).

    Article  CAS  Google Scholar 

  42. Zhang, W. & Lehmann, P. Objective, user-independent ELISPOT data analysis based on scientifically validated principles. Methods Mol. Biol. 792, 155–171 (2012).

    Article  CAS  Google Scholar 

  43. Janetzki, S. & Britten, C.M. The impact of harmonization on ELISPOT assay performance. Methods Mol. Biol. 792, 25–36 (2012).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We thank M. Ali for advice on data analyses and P. Sharma for technical and logistical support. This article describes protocols that have matured from studies supported in part by the Bill & Melinda Gates Foundation (grants OPP1017157 and PROVIDE), the European Union Seventh Framework Program (grant 280873 ADITEC), the World Health Organization (WHO; Global Polio Eradication Program), PATH Vaccine Solutions (EVI Program), Institut National de la Santé et de la Recherche Médicale (INSERM, France), the Swedish Agency for International Cooperation (SIDA) and the Swedish National Research Council. Merck Vaccines (USA), Green Cross Vaccines (South Korea), Sanofi-Pasteur (France), Crucell (the Netherlands) and the National Institute for Public Health and the Environment (RIVM, the Netherlands) are kindly acknowledged for providing reagents and vaccines. The International Vaccine Institute is supported by the governments of the Republic of Korea, Sweden and the Netherlands.

Author information

Authors and Affiliations

Authors

Contributions

G.S., N.Ç. and C.C. designed the experiments. G.S., N.Ç., J.S.Y. and A.D. performed the experiments and analyzed data. G.S., A.D. and C.C. wrote the paper.

Corresponding author

Correspondence to Cecil Czerkinsky.

Ethics declarations

Competing interests

The authors declare no competing financial interests.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Saletti, G., Çuburu, N., Yang, J. et al. Enzyme-linked immunospot assays for direct ex vivo measurement of vaccine-induced human humoral immune responses in blood. Nat Protoc 8, 1073–1087 (2013). https://doi.org/10.1038/nprot.2013.058

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nprot.2013.058

This article is cited by

Comments

By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing